January 4, 2018 / 4:31 AM / 7 months ago

BRIEF-Mycenax Biotech gets approval for 1st phase human clinical trial for LusiNEX

Jan 4 (Reuters) - Mycenax Biotech Inc :

* Says it gets approval from UK’s MHRA to commence the first phase human clinical trial for biosimilars LusiNEX, a kind of drug for treatment of rheumatoid arthritis

Source text in Chinese: goo.gl/nDRSXA

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below